184 related articles for article (PubMed ID: 30359562)
21. Correction of impaired calmodulin binding to RyR2 as a novel therapy for lethal arrhythmia in the pressure-overloaded heart failure.
Kato T; Yamamoto T; Nakamura Y; Nanno T; Fukui G; Sufu Y; Hamada Y; Maeda T; Nishimura S; Ishiguchi H; Murakami W; Fukuda M; Xu X; Hino A; Ono M; Oda T; Okuda S; Kobayashi S; Koseki N; Kyushiki H; Yano M
Heart Rhythm; 2017 Jan; 14(1):120-127. PubMed ID: 27771553
[TBL] [Abstract][Full Text] [Related]
22. Ryanodine receptor-bound calmodulin is essential to protect against catecholaminergic polymorphic ventricular tachycardia.
Nakamura Y; Yamamoto T; Kobayashi S; Tamitani M; Hamada Y; Fukui G; Xu X; Nishimura S; Kato T; Uchinoumi H; Oda T; Okuda S; Yano M
JCI Insight; 2019 Jun; 4(11):. PubMed ID: 31167968
[TBL] [Abstract][Full Text] [Related]
23. In cardiomyocytes, binding of unzipping peptide activates ryanodine receptor 2 and reciprocally inhibits calmodulin binding.
Oda T; Yang Y; Nitu FR; Svensson B; Lu X; Fruen BR; Cornea RL; Bers DM
Circ Res; 2013 Feb; 112(3):487-97. PubMed ID: 23233753
[TBL] [Abstract][Full Text] [Related]
24. Calmodulin binding and inhibition of cardiac muscle calcium release channel (ryanodine receptor).
Balshaw DM; Xu L; Yamaguchi N; Pasek DA; Meissner G
J Biol Chem; 2001 Jun; 276(23):20144-53. PubMed ID: 11274202
[TBL] [Abstract][Full Text] [Related]
25. Herpud1 modulates hypertrophic signals independently of calmodulin nuclear translocation in rat myocardium-derived H9C2 cells.
Fujioka R; Yamamoto T; Maruta A; Nakamura Y; Tominaga N; Inamitsu M; Oda T; Kobayashi S; Yano M
Biochem Biophys Res Commun; 2023 Apr; 652():61-67. PubMed ID: 36812708
[TBL] [Abstract][Full Text] [Related]
26. Ca2+-calmodulin increases RyR2 open probability yet reduces ryanoid association with RyR2.
Sigalas C; Mayo-Martin MB; Jane DE; Sitsapesan R
Biophys J; 2009 Oct; 97(7):1907-16. PubMed ID: 19804721
[TBL] [Abstract][Full Text] [Related]
27. Aberrant interaction of calmodulin with the ryanodine receptor develops hypertrophy in the neonatal cardiomyocyte.
Gangopadhyay JP; Ikemoto N
Biochem J; 2011 Sep; 438(2):379-87. PubMed ID: 21649588
[TBL] [Abstract][Full Text] [Related]
28. Calmodulin inhibition of human RyR2 channels requires phosphorylation of RyR2-S2808 or RyR2-S2814.
Walweel K; Gomez-Hurtado N; Rebbeck RT; Oo YW; Beard NA; Molenaar P; Dos Remedios C; van Helden DF; Cornea RL; Knollmann BC; Laver DR
J Mol Cell Cardiol; 2019 May; 130():96-106. PubMed ID: 30928430
[TBL] [Abstract][Full Text] [Related]
29. Ca
Brohus M; Søndergaard MT; Wayne Chen SR; van Petegem F; Overgaard MT
Biochem J; 2019 Jan; 476(2):193-209. PubMed ID: 30530841
[TBL] [Abstract][Full Text] [Related]
30. Essential Role of Calmodulin in RyR Inhibition by Dantrolene.
Oo YW; Gomez-Hurtado N; Walweel K; van Helden DF; Imtiaz MS; Knollmann BC; Laver DR
Mol Pharmacol; 2015 Jul; 88(1):57-63. PubMed ID: 25920678
[TBL] [Abstract][Full Text] [Related]
31. Altered RyR2 regulation by the calmodulin F90L mutation associated with idiopathic ventricular fibrillation and early sudden cardiac death.
Nomikos M; Thanassoulas A; Beck K; Vassilakopoulou V; Hu H; Calver BL; Theodoridou M; Kashir J; Blayney L; Livaniou E; Rizkallah P; Nounesis G; Lai FA
FEBS Lett; 2014 Aug; 588(17):2898-902. PubMed ID: 25036739
[TBL] [Abstract][Full Text] [Related]
32. Calmodulin modulates the termination threshold for cardiac ryanodine receptor-mediated Ca2+ release.
Tian X; Tang Y; Liu Y; Wang R; Chen SR
Biochem J; 2013 Nov; 455(3):367-75. PubMed ID: 23992453
[TBL] [Abstract][Full Text] [Related]
33. A peptide of the N terminus of GRK5 attenuates pressure-overload hypertrophy and heart failure.
Coleman RC; Eguchi A; Lieu M; Roy R; Barr EW; Ibetti J; Lucchese AM; Peluzzo AM; Gresham K; Chuprun JK; Koch WJ
Sci Signal; 2021 Mar; 14(676):. PubMed ID: 33785612
[TBL] [Abstract][Full Text] [Related]
34. Dyad content is reduced in cardiac myocytes of mice with impaired calmodulin regulation of RyR2.
Lavorato M; Huang TQ; Iyer VR; Perni S; Meissner G; Franzini-Armstrong C
J Muscle Res Cell Motil; 2015 Apr; 36(2):205-14. PubMed ID: 25694159
[TBL] [Abstract][Full Text] [Related]
35. EL20, a potent antiarrhythmic compound, selectively inhibits calmodulin-deficient ryanodine receptor type 2.
Klipp RC; Li N; Wang Q; Word TA; Sibrian-Vazquez M; Strongin RM; Wehrens XHT; Abramson JJ
Heart Rhythm; 2018 Apr; 15(4):578-586. PubMed ID: 29248564
[TBL] [Abstract][Full Text] [Related]
36. Enhanced binding of calmodulin to RyR2 corrects arrhythmogenic channel disorder in CPVT-associated myocytes.
Fukuda M; Yamamoto T; Nishimura S; Kato T; Murakami W; Hino A; Ono M; Tateishi H; Oda T; Okuda S; Kobayashi S; Koseki N; Kyushiki H; Yano M
Biochem Biophys Res Commun; 2014 May; 448(1):1-7. PubMed ID: 24755079
[TBL] [Abstract][Full Text] [Related]
37. Distinct structural features of G protein-coupled receptor kinase 5 (GRK5) regulate its nuclear localization and DNA-binding ability.
Johnson LR; Robinson JD; Lester KN; Pitcher JA
PLoS One; 2013; 8(5):e62508. PubMed ID: 23658733
[TBL] [Abstract][Full Text] [Related]
38. Requirement for Ca2+/calmodulin-dependent kinase II in the transition from pressure overload-induced cardiac hypertrophy to heart failure in mice.
Ling H; Zhang T; Pereira L; Means CK; Cheng H; Gu Y; Dalton ND; Peterson KL; Chen J; Bers D; Brown JH
J Clin Invest; 2009 May; 119(5):1230-40. PubMed ID: 19381018
[TBL] [Abstract][Full Text] [Related]
39. Arrhythmia-Associated Calmodulin E105A Mutation Alters the Binding Affinity of CaM to a Ryanodine Receptor 2 CaM-Binding Pocket.
Thanassoulas A; Theodoridou M; Barrak L; Riguene E; Alyaarabi T; Elrayess MA; Lai FA; Nomikos M
Int J Mol Sci; 2023 Oct; 24(21):. PubMed ID: 37958614
[TBL] [Abstract][Full Text] [Related]
40. Two EF-hand motifs in ryanodine receptor calcium release channels contribute to isoform-specific regulation by calmodulin.
Xu L; Gomez AC; Pasek DA; Meissner G; Yamaguchi N
Cell Calcium; 2017 Sep; 66():62-70. PubMed ID: 28807150
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
